Location: Home
  • search
  • go
  • Relate News
  • 1/23/2018Clover Biopharma to Make Biosimilars in China with GE Facility
  • 1/23/2018Cardiome Announces Expanded Label for Aggrastat in China
  • 1/23/2018GSK Launches Triple-threapy HIV Drug Triumeq in Mainland China with Co...
  • 1/23/2018IQVIA: Chinese Hospital Drug Sales Up 6.2% in Q3/2017
  • 1/23/2018IQVIA: Chinese Retail Pharmacy Sales Up 2. 6% in MAT Q3/2017
  • 1/22/2018USTR's 2017 Report for China's WTO Compliance Highlight IP Issues in P...
  • 1/19/2018118 Listed Chinese Pharma Cos Report 2017 Performance Guidance
  • 1/19/2018Recent Executive Moves
  • 1/19/2018Ascletis Seeks Third Round of Funding That Could Exceed US$100M
  • 1/19/2018Made in China: New and Potentially Lifesaving Drugs
  • 1/19/2018Mundipharma to Take Over Marketing of Grunenthal's Pain-Relief Drug in...
  • 1/19/2018CFDA Approves New Indication of Mitsubishi Tanabe's Novastan
  • 1/19/2018CITIC Capital Becomes Controlling Shareholder of Harbin Pharma
  • 1/18/2018EMA Bans Amoxicillin API from Changsheng Pharma after Identifying Defi...
  • 1/18/2018Hua Medicine Mulls Hong Kong IPO as Diabetes Drug Enters Crucial Clini...
  • 1/18/2018Xbrane, CR Pharma Sign Letter of Intent for Lucentis Biosimilar in Chi...
  • 1/17/2018Amarin Announces Commencement of VASCEPA Clinical Development in Mainl...
  • 1/17/2018China's Medical Representative Registration System: Action Items for P...
  • 1/17/20183SBio Licenses Mainland China Rights of Toray's Antipruritic Agent TRK...
  • 1/16/2018Clinical Trials Registered on the CDE Platform Rebound to a New Peak i...
  • 1/16/2018Data Snapshot: Overseas Out-licensing Deals of Novel Drugs Developed i...
  • 1/15/2018Overview of Chinese Drug Approvals in 2017
  • 1/15/2018CFDA Releases List of Newly Approved Professional Journals Approved fo...
  • 1/12/2018BeiGene and Mirati Announce Exclusive License Agreement for Sitravatin...
  • 1/11/2018CFDA Seeks Comments on the Amendments of Administrative Measures for D...
  • 1/11/2018Recent Executive Moves
  • 1/11/2018Ten Contemporary Chinese Biopharma Industry Predictions in 2018
  • 1/10/2018Data Snapshot: Chinese Hospital Consumption of Cholesterol-Reduction D...
  • 1/10/2018Indigenously-developed Class 1 New Chemical Drugs Approved in China 20...
  • 1/10/2018CPIIC: Chinese Urban Hospital Drug Market Expected to be Flat in 2017
  • Page:184/371 Total number of articles:11127: [First][<<] [182] [183] [184] [185] [186] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group